FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4384401382> ?p ?o ?g. }

• W4384401382 endingPage "402" @default.
• W4384401382 startingPage "391" @default.
• W4384401382 abstract "Abstract Aim Continued antipsychotic treatment is the key to preventing relapse. Maintenance antipsychotic monotherapy and optimal dose use are recommended for individuals with stable schizophrenia because of their undesirable effects. Decision aids (DAs) are clinical conversation tools that facilitate shared decision‐making (SDM) between patients and health‐care providers. This study aimed to describe the development process and results of acceptability testing of a DA for individuals with stable schizophrenia, considering (i) whether to continue high‐dose antipsychotics or reduce to the standard dose and (ii) whether to continue two antipsychotics or shift to monotherapy. Methods A DA was developed according to the guidelines for the appropriate use of psychotropic medications and International Patient Decision Aid Standards (IPDAS). First, a DA prototype was developed based on a previous systematic review and meta‐analysis conducted for identifying the effects of continuing or reducing antipsychotic treatment. Second, mixed‐method survey was performed among individuals with schizophrenia and health‐care providers to modify and finalize the DA. Results The DA consisted of an explanation of schizophrenia, options to continue high‐dose antipsychotics or reduce to the standard dose, options to continue two antipsychotics or shift to monotherapy, pros and cons of each option, and a value‐clarification worksheet for each option. The patients ( n = 20) reported acceptable language use (75%), adequate information (75%), and well‐balanced presentation (79%). Health‐care providers ( n = 20) also provided favorable overall feedback. The final DA covered six IPDAS qualifying criteria. Conclusion A DA was successfully developed for schizophrenia, considering whether to reduce antipsychotics, which can be used in the SDM process." @default.
• W4384401382 created "2023-07-16" @default.
• W4384401382 creator A5006005694 @default.
• W4384401382 creator A5009945280 @default.
• W4384401382 creator A5017649309 @default.
• W4384401382 creator A5017868441 @default.
• W4384401382 creator A5019563298 @default.
• W4384401382 creator A5025793368 @default.
• W4384401382 creator A5030446932 @default.
• W4384401382 creator A5038443133 @default.
• W4384401382 creator A5040604548 @default.
• W4384401382 creator A5042335595 @default.
• W4384401382 creator A5047079744 @default.
• W4384401382 creator A5061811239 @default.
• W4384401382 creator A5071803905 @default.
• W4384401382 date "2023-07-14" @default.
• W4384401382 modified "2023-10-17" @default.
• W4384401382 title "Development and acceptability testing of a decision aid for considering whether to reduce antipsychotics in individuals with stable schizophrenia" @default.
• W4384401382 cites W1943745580 @default.
• W4384401382 cites W1970399685 @default.
• W4384401382 cites W1978408850 @default.
• W4384401382 cites W1998390365 @default.
• W4384401382 cites W2011675347 @default.
• W4384401382 cites W2023992279 @default.
• W4384401382 cites W2032704604 @default.
• W4384401382 cites W2037394322 @default.
• W4384401382 cites W2046882118 @default.
• W4384401382 cites W2071677582 @default.
• W4384401382 cites W2072682434 @default.
• W4384401382 cites W2130597901 @default.
• W4384401382 cites W2145619523 @default.
• W4384401382 cites W2171956687 @default.
• W4384401382 cites W2329387641 @default.
• W4384401382 cites W2402993095 @default.
• W4384401382 cites W2586430759 @default.
• W4384401382 cites W2611085728 @default.
• W4384401382 cites W2753988500 @default.
• W4384401382 cites W2888758693 @default.
• W4384401382 cites W2905472245 @default.
• W4384401382 cites W2953969325 @default.
• W4384401382 cites W2973597900 @default.
• W4384401382 cites W2990976623 @default.
• W4384401382 cites W3034282824 @default.
• W4384401382 cites W3037941153 @default.
• W4384401382 cites W3042390659 @default.
• W4384401382 cites W3047982353 @default.
• W4384401382 cites W3121063030 @default.
• W4384401382 cites W3150351464 @default.
• W4384401382 cites W3215478284 @default.
• W4384401382 cites W3217665231 @default.
• W4384401382 cites W4211145950 @default.
• W4384401382 cites W4283755212 @default.
• W4384401382 cites W4308804566 @default.
• W4384401382 cites W4308958907 @default.
• W4384401382 cites W4384401382 @default.
• W4384401382 doi "https://doi.org/10.1002/npr2.12366" @default.
• W4384401382 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37452456" @default.
• W4384401382 hasPublicationYear "2023" @default.
• W4384401382 type Work @default.
• W4384401382 citedByCount "1" @default.
• W4384401382 countsByYear W43844013822023 @default.
• W4384401382 crossrefType "journal-article" @default.
• W4384401382 hasAuthorship W4384401382A5006005694 @default.
• W4384401382 hasAuthorship W4384401382A5009945280 @default.
• W4384401382 hasAuthorship W4384401382A5017649309 @default.
• W4384401382 hasAuthorship W4384401382A5017868441 @default.
• W4384401382 hasAuthorship W4384401382A5019563298 @default.
• W4384401382 hasAuthorship W4384401382A5025793368 @default.
• W4384401382 hasAuthorship W4384401382A5030446932 @default.
• W4384401382 hasAuthorship W4384401382A5038443133 @default.
• W4384401382 hasAuthorship W4384401382A5040604548 @default.
• W4384401382 hasAuthorship W4384401382A5042335595 @default.
• W4384401382 hasAuthorship W4384401382A5047079744 @default.
• W4384401382 hasAuthorship W4384401382A5061811239 @default.
• W4384401382 hasAuthorship W4384401382A5071803905 @default.
• W4384401382 hasBestOaLocation W43844013821 @default.
• W4384401382 hasConcept C118552586 @default.
• W4384401382 hasConcept C145420912 @default.
• W4384401382 hasConcept C15744967 @default.
• W4384401382 hasConcept C160735492 @default.
• W4384401382 hasConcept C162324750 @default.
• W4384401382 hasConcept C176734034 @default.
• W4384401382 hasConcept C2776412080 @default.
• W4384401382 hasConcept C2780494398 @default.
• W4384401382 hasConcept C50522688 @default.
• W4384401382 hasConcept C71924100 @default.
• W4384401382 hasConceptScore W4384401382C118552586 @default.
• W4384401382 hasConceptScore W4384401382C145420912 @default.
• W4384401382 hasConceptScore W4384401382C15744967 @default.
• W4384401382 hasConceptScore W4384401382C160735492 @default.
• W4384401382 hasConceptScore W4384401382C162324750 @default.
• W4384401382 hasConceptScore W4384401382C176734034 @default.
• W4384401382 hasConceptScore W4384401382C2776412080 @default.
• W4384401382 hasConceptScore W4384401382C2780494398 @default.
• W4384401382 hasConceptScore W4384401382C50522688 @default.
• W4384401382 hasConceptScore W4384401382C71924100 @default.
• W4384401382 hasIssue "3" @default.
• W4384401382 hasLocation W43844013821 @default.

• next